Literature DB >> 19264734

Critical illness polyneuromyopathy in a child with severe demyelinating myelitis.

Tanja Adamovic1, Ariane Willems, Michel Vanasse, Guy D'Anjou, Yves Robitaille, Catherine Litalien, France Gauvin.   

Abstract

We report a child presenting with severe demyelinating myelitis complicated with critical illness polyneuropathy. This previously healthy 8-month-old boy presented with acute superior limb weakness, absent tendon reflexes, and respiratory failure. Spinal magnetic resonance imaging showed an extensive cervical demyelinating lesion. Spinal cord trauma was suspected and high doses of dexamethasone were administered. Electromyography and nerve conduction studies showed absence of compound muscle action potentials and sural nerve sensory action potential, which was suggestive of a severe Guillain-Barré syndrome. However, intravenous immunoglobulins did not induce any improvement. Afterward, sural nerve biopsy showed a mild neuropathy, but muscle biopsy revealed abnormalities compatible with severe critical illness myopathy. After 5 months of evolution without improvement, the patient died following withdrawal of life support therapy. This case highlights the possible occurrence of critical illness polyneuromyopathy when treatment with corticosteroids are used in patients with acute demyelinating myelitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264734     DOI: 10.1177/0883073808330166

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Concomitant acute transverse myelitis and sensory motor axonal polyneuropathy in two children: two case reports.

Authors:  Hyung Chung; Kyung-Lim Joa; Hyo-Sang Kim; Chang-Hwan Kim; Han-Young Jung; Myeong Ok Kim
Journal:  Ann Rehabil Med       Date:  2015-02-28

2.  Intensive care unit acquired weakness in children: Critical illness polyneuropathy and myopathy.

Authors:  Vinay Kukreti; Mosharraf Shamim; Praveen Khilnani
Journal:  Indian J Crit Care Med       Date:  2014-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.